# Myosin Class I Genes Follow a Cell Type-Specific Transcription Pattern in Human Haematopoietic Cell Lines

**Authors:** Alexandra E. Golysheva, Anna V. Tvorogova, Artyom A. Tyukaev, Aleena A. Saidova, Daria M. Potashnikova

PMC · DOI: 10.3390/ijms27041777 · International Journal of Molecular Sciences · 2026-02-12

## TL;DR

This paper studies how different myosin class I genes are expressed in human blood cell lines, revealing cell-specific patterns that could help understand their roles in disease.

## Contribution

The study introduces a qPCR system and re-analyzes RNA-seq data to reveal cell-type-specific expression patterns of all eight human MYO1 genes.

## Key findings

- MYO1 genes show restricted and cell-type-specific expression patterns in human cell lines.
- A qPCR system was developed and validated for screening human myosin I expression.
- The study highlights unique expression profiles in haematopoietic cell lines.

## Abstract

Class I myosins form an abundant group of single-headed motor proteins that interact with actin and membrane phospholipids and are employed in a variety of cell processes like cell shape remodeling, motility and invasion, exocytosis, and endocytosis. The large number of class members and their uneven distribution in human cells and tissues complicate their study. Furthermore, this hinders the assessment of their biomarker potential and mechanistic role in oncogenesis and other diseases. Despite the emerging data on their mutations and altered abundance in a number of tumors and other diseases, most studies examine class I myosins individually or in groups of several proteins. Thus, the question of their redundancy and possible functional substitution is ignored. In this work, we simultaneously assess all eight human MYO1 genes on cell lines of different origins by RNA-seq re-analysis. We also report a qPCR system for human myosin I screening and test it on a set of 35 continuous cell lines widely used in biomedicine and fundamental research. These data clarify the restricted expression patterns of MYO1 genes in various human cell types and allow to assess the pattern specific of haematopoietic cell lines.

## Linked entities

- **Genes:** myo-1 (Myosin-1) [NCBI Gene 172471]
- **Proteins:** ACTIN (hypothetical protein)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** MYH14 (myosin heavy chain 14) [NCBI Gene 79784] {aka DFNA4, DFNA4A, FP17425, MHC16, MYH17, NMHC II-C}, Myo1a (myosin IA) [NCBI Gene 432516] {aka BBM-I, Myhl}, MYO1D (myosin ID) [NCBI Gene 4642] {aka PPP1R108, myr4}, MYO1F (myosin IF) [NCBI Gene 4542], DNAH8 (dynein axonemal heavy chain 8) [NCBI Gene 1769] {aka ATPase, SPGF46, hdhc9}, MYOF (myoferlin) [NCBI Gene 26509] {aka FER1L3, HAE7}, YWHAZ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta) [NCBI Gene 7534] {aka 14-3-3-zeta, HEL-S-3, HEL-S-93, HEL4, KCIP-1, POPCHAS}, MYO1E (myosin IE) [NCBI Gene 4643] {aka FSGS6, HuncM-IC, MYO1C}, UBC (ubiquitin C) [NCBI Gene 7316] {aka HMG20}, MYO1H (myosin IH) [NCBI Gene 283446] {aka CCHS2}, Myo1e (myosin IE) [NCBI Gene 71602] {aka 2310020N23Rik, 9130023P14Rik, myosin-1e, myr 3}, MYO1B (myosin IB) [NCBI Gene 4430] {aka MMI-alpha, MMIa, MYH-1c, myr1}, EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}, Myo1c (myosin IC) [NCBI Gene 17913] {aka MMIb, MYO1E, NMI, mm1beta, myr2}, MYO1A (myosin IA) [NCBI Gene 4640] {aka BBMI, DFNA48, DIAR15, MIHC, MYHL}, MYO1C (myosin IC) [NCBI Gene 4641] {aka MMI-beta, MMIb, MyoIC, NMI, myr2}, MNT (MAX network transcriptional repressor) [NCBI Gene 4335] {aka MAD6, MXD6, ROX, bHLHd3, lncRNA-HAL}, MYO1G (myosin IG) [NCBI Gene 64005] {aka HA2, HLA-HA2, MHAG}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, Myo1d (myosin ID) [NCBI Gene 338367] {aka 9930104H07Rik, D11Ertd9e, myosin-1d}
- **Diseases:** ovarian carcinoma (MESH:D010051), congenital central hypoventilation syndrome (MESH:C536209), lung and breast carcinoma (MESH:D001943), fibroma (MESH:D005350), prostatic carcinoma (MESH:D011472), glioblastomas (MESH:D005909), IG (MESH:C564643), HCC (MESH:D006528), UMAP (MESH:C567162), leukemia (MESH:D007938), colon cancer (MESH:D015179), blood disorders (MESH:D006402), metastases (MESH:D009362), acute lymphoblastic leukemia (MESH:D054198), neurological tumors (MESH:D009423), oncogenesis (MESH:D063646), colon carcinoma (MESH:D003110), HNSCC (MESH:D000077195), sarcoma (MESH:D012509), spastic spinal paraplegia (MESH:D010264), neuroblastomas (MESH:D009447), IH (MESH:C565524), pancreatic carcinoma (MESH:D010190), cervical cancer (MESH:D002583), acute monocytic leukemia (MESH:D007948), injury to (MESH:D014947), inflammatory (MESH:D007249), epithelial tumors (MESH:D002277), liver fibrosis (MESH:D008103), Haematologic malignancies (MESH:D009369), NAFLD (MESH:D065626), lung carcinoma (MESH:D008175)
- **Chemicals:** agarose (MESH:D012685), CO2 (MESH:D002245), L-glutamine (MESH:D005973), SYBR Green I (MESH:C098022), acetate (MESH:D000085), penicillin (MESH:D010406), DMEM (-), phospholipids (MESH:D010743), OrangeG (MESH:C008710), TAE buffer (MESH:C115179), oligonucleotides (MESH:D009841), phosphoinositides (MESH:D010716), streptomycin (MESH:D013307), EDTA (MESH:D004492), hydrocortisone (MESH:D006854), Ethidium bromide (MESH:D004996)
- **Species:** Moloney murine leukemia virus (no rank) [taxon 11801], Homo sapiens (human, species) [taxon 9606], Acanthamoeba (genus) [taxon 5754], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** PANC-1 — Homo sapiens (Human), Pancreatic ductal adenocarcinoma, Cancer cell line (CVCL_0480), OVCAR-3 — Homo sapiens (Human), High grade ovarian serous adenocarcinoma, Cancer cell line (CVCL_0465), AsPC1 — Homo sapiens (Human), Pancreatic ductal adenocarcinoma, Cancer cell line (CVCL_0152), Capan-2 — Homo sapiens (Human), Pancreatic ductal adenocarcinoma, Cancer cell line (CVCL_0026), RWPE-1 — Homo sapiens (Human), Transformed cell line (CVCL_3791), OVCAR-8 — Homo sapiens (Human), High grade ovarian serous adenocarcinoma, Cancer cell line (CVCL_1629), LnCaP — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_0395), SKOV3 — Homo sapiens (Human), Ovarian serous cystadenocarcinoma, Cancer cell line (CVCL_0532), HT29 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0320), Wi38 — Homo sapiens (Human), Finite cell line (CVCL_0579), CaCO-2 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0025), Keratinocyte-SFM — Rattus norvegicus (Rat), Spontaneously immortalized cell line (CVCL_C7RU), THP-1 — Homo sapiens (Human), Childhood acute monocytic leukemia, Cancer cell line (CVCL_0006), Jurkat — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_0065), MCF10A — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0598), SW480 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0546), MDA-MB-231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062), T-47D — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0553), HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), H358 — Homo sapiens (Human), Minimally invasive lung adenocarcinoma, Cancer cell line (CVCL_1559), HCT-116 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_0291), EFO-21 — Homo sapiens (Human), Ovarian serous cystadenocarcinoma, Cancer cell line (CVCL_0029), SW837 — Homo sapiens (Human), Rectal adenocarcinoma, Cancer cell line (CVCL_1729), H1299 — Homo sapiens (Human), Lung large cell carcinoma, Cancer cell line (CVCL_0060), H460 — Homo sapiens (Human), Lung large cell carcinoma, Cancer cell line (CVCL_0459), DU-145 — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_0105), MOLT-4 — Homo sapiens (Human), Adult T acute lymphoblastic leukemia, Cancer cell line (CVCL_0013), K-562 — Homo sapiens (Human), Blast phase chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_0004), MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), HBL-100 — Homo sapiens (Human), Transformed cell line (CVCL_4362), MIAPaCa-2 — Homo sapiens (Human), Pancreatic undifferentiated carcinoma, Cancer cell line (CVCL_0428), RPMI-8866 — Homo sapiens (Human), Chronic myelogenous leukemia, BCR-ABL1 positive, Transformed cell line (CVCL_1668), HL-60 — Homo sapiens (Human), Adult acute myeloid leukemia with maturation, Cancer cell line (CVCL_0002), Raji — Homo sapiens (Human), EBV-related Burkitt lymphoma, Cancer cell line (CVCL_0511), CEM/C1 — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_3496), RPMI-8226 — Homo sapiens (Human), Plasma cell myeloma, Cancer cell line (CVCL_0014), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), HAP-1 — Homo sapiens (Human), Chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_Y019)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12940969/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940969/full.md

## References

67 references — full list in the complete paper: https://tomesphere.com/paper/PMC12940969/full.md

---
Source: https://tomesphere.com/paper/PMC12940969